These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 16033621
1. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Bussone G, Diener HC, Pfeil J, Schwalen S. Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621 [Abstract] [Full Text] [Related]
2. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials. Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P. CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838 [Abstract] [Full Text] [Related]
3. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies. MacGregor EA, Pawsey SP, Campbell JC, Hu X. Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272 [Abstract] [Full Text] [Related]
4. Oral budesonide for induction of remission in ulcerative colitis. Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH. Cochrane Database Syst Rev; 2015 Oct 26; 2015(10):CD007698. PubMed ID: 26497719 [Abstract] [Full Text] [Related]
5. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P, Landy S, Richardson M, Ames M. Clin Ther; 2005 Nov 26; 27(11):1785-94. PubMed ID: 16368449 [Abstract] [Full Text] [Related]
6. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Cochrane Database Syst Rev; 2013 Jun 24; 2013(6):CD010611. PubMed ID: 23797677 [Abstract] [Full Text] [Related]
7. Tramadol for neuropathic pain in adults. Duehmke RM, Derry S, Wiffen PJ, Bell RF, Aldington D, Moore RA. Cochrane Database Syst Rev; 2017 Jun 15; 6(6):CD003726. PubMed ID: 28616956 [Abstract] [Full Text] [Related]
8. Interventions for treating lymphocytic colitis. Chande N, Al Yatama N, Bhanji T, Nguyen TM, McDonald JW, MacDonald JK. Cochrane Database Syst Rev; 2017 Jul 13; 7(7):CD006096. PubMed ID: 28702956 [Abstract] [Full Text] [Related]
9. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Wang Y, Parker CE, Feagan BG, MacDonald JK. Cochrane Database Syst Rev; 2016 May 09; 2016(5):CD000544. PubMed ID: 27158764 [Abstract] [Full Text] [Related]
10. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Feagan BG, Macdonald JK. Cochrane Database Syst Rev; 2012 Oct 17; 10():CD000544. PubMed ID: 23076890 [Abstract] [Full Text] [Related]
11. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Cochrane Database Syst Rev; 2014 Apr 27; 2014(4):CD007938. PubMed ID: 24771480 [Abstract] [Full Text] [Related]
12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF. Health Technol Assess; 2022 Oct 27; 26(44):1-310. PubMed ID: 36321689 [Abstract] [Full Text] [Related]
13. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis. Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G. Cochrane Database Syst Rev; 2013 Jun 06; 2013(6):CD008933. PubMed ID: 23744561 [Abstract] [Full Text] [Related]
14. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Health Technol Assess; 2021 Dec 06; 25(75):1-134. PubMed ID: 34931602 [Abstract] [Full Text] [Related]
15. Drug therapy for obstructive sleep apnoea in adults. Mason M, Welsh EJ, Smith I. Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD003002. PubMed ID: 23728641 [Abstract] [Full Text] [Related]
16. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH. Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924 [Abstract] [Full Text] [Related]
17. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial. Vermeire S, Schreiber S, Rubin DT, D'Haens G, Reinisch W, Watanabe M, Mehta R, Roblin X, Beales I, Gietka P, Hibi T, Hospodarskyy I, Ritter T, Genovese MC, Kwon P, Santermans E, Le Brun FO, Barron R, Masior T, Danese S. Lancet Gastroenterol Hepatol; 2024 Dec 02. PubMed ID: 39637881 [Abstract] [Full Text] [Related]
18. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J, Gaudet LA, Saba S, Vandermeer B, Ashiq AR, Wingert A, Hartling L. Syst Rev; 2024 Nov 26; 13(1):289. PubMed ID: 39593159 [Abstract] [Full Text] [Related]
19. Morphine for chronic neuropathic pain in adults. Cooper TE, Chen J, Wiffen PJ, Derry S, Carr DB, Aldington D, Cole P, Moore RA. Cochrane Database Syst Rev; 2017 May 22; 5(5):CD011669. PubMed ID: 28530786 [Abstract] [Full Text] [Related]
20. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P, Sanchez AM, Penke TJR, Tuson HH, Kime JC, McKee RW, Slone WL, Conley NR, McMillan LJ, Prybol CJ, Garofolo PM. Lancet Infect Dis; 2024 Dec 22; 24(12):1319-1332. PubMed ID: 39134085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]